August 30, 2012
A New Jersey federal judge on Wednesday trimmed securities fraud claims in multidistrict litigation against Merck & Co. Inc. and its executives after employee pension plans claimed they had misrepresented the company's financial health by hiding the heart risks of its recalled arthritis medication Vioxx.
August 09, 2011
A New Jersey federal judge on Monday preserved most claims against Merck & Co. Inc. in a securities class action filed by employee investors claiming the company inflated stock prices by downplaying a possible link between heart attack risks and its shelved painkiller Vioxx.